Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;25(9):1910-1919.
doi: 10.1038/s41380-020-0709-5. Epub 2020 Mar 13.

Binding of clozapine to the GABAB receptor: clinical and structural insights

Affiliations
Review

Binding of clozapine to the GABAB receptor: clinical and structural insights

Pramod C Nair et al. Mol Psychiatry. 2020 Sep.

Abstract

Clozapine is the gold-standard agent for treatment resistant schizophrenia but its mechanism of action remains unclear. There is emerging evidence of the potential role of the GABAB receptor in the pathogenesis of schizophrenia. It has been hypothesised that clozapine can mediate its actions via the GABAB receptor. Baclofen is currently recognised as the prototype GABAB receptor agonist. There are some potential clinical similarities between clozapine and baclofen. Indeed, baclofen has been previously proposed for use as an antipsychotic agent. Our analysis of the X-ray crystal structure of GABAB receptor along with molecular docking calculations, suggests that clozapine could directly bind to the GABAB receptor similar to that of baclofen. This finding could lead to a better understanding of the pharmacological uniqueness of clozapine, potential development of a biomarker for treatment resistant schizophrenia and the development of more targeted treatments leading to personalisation of treatment.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. Insel TR. Rethinking schizophrenia. Nature. 2010;468:187–93. - PubMed - DOI
    1. Van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635–45. - PubMed - DOI
    1. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67–76. - PubMed - DOI
    1. Marwaha S, Johnson S, Bebbington P, Stafford M, Angermeyer MC, Brugha T, et al. Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry. 2007;191:30–37. - PubMed - DOI
    1. Siskind D, Siskind V, Kisely S. Clozapine response rates among people with treatment-resistant schizophrenia data from a systematic review and meta-analysis. Can J Psychiatry. 2017;62:772–7. - PubMed - PMC - DOI

LinkOut - more resources